Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated EV71 vaccine in Chinese infants
NCT01512706Phase 2Completed
- Sponsor
- Institute of Medical Biology
- Start
- Jul 2011
- Primary completion
- Jan 2012
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inactivated enterovirus 71 vaccine in hand, foot, and mouth disease (HFMD) (5 arms), sponsored by Institute of Medical Biology. Primary endpoints: Safety within 28 days after first vaccination and Safety within 56 days after second vaccination. Started Jul 2011; status: completed.
02
Drugs
inactivated enterovirus 71 vaccine
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on NCT01512706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01512706.